Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 28, 2016; 22(48): 10592-10600
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10592
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10592
Age at surveillance | Total patient-years follow-up | Adenocarcinoma | High-grade dysplasia and adenocarcinoma | All grades of dysplasia and adenocarcinoma | |||
Number of cases | Annual incidence | Number of cases | Annual incidence | Number of cases | Annual incidence | ||
< 40 | 236 | 0 | 0.00% | 1 | 0.42% | 4 | 1.89% |
40-49 | 740 | 0 | 0.00% | 2 | 0.27% | 15 | 2.30% |
50-59 | 1602 | 6 | 0.37% | 9 | 0.56% | 39 | 2.82% |
60-69 | 2154 | 15 | 0.70% | 20 | 0.94% | 63 | 3.66% |
70-79 | 1464 | 20 | 1.37% | 26 | 1.81% | 52 | 4.49% |
80+ | 278 | 13 | 4.67% | 12 | 4.34% | 17 | 7.18% |
Total | 6474 | 54 | 0.83% | 70 | 1.09% | 190 | 3.54% |
- Citation: Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600
- URL: https://www.wjgnet.com/1007-9327/full/v22/i48/10592.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i48.10592